Mylan Wins Bid To Block Apotex's Generic Paxil
Mylan Inc. won an order Tuesday barring Apotex Inc. from making a generic form of GlaxoSmithKline PLC's Paxil, in a suit that accuses the brand-name drugmaker and Apotex of seeking to...To view the full article, register now.
Already a subscriber? Click here to view full article